Given that all trials carry an element of risk, experts believe that there is an "unfair" burden-benefit ratio on the Indian population when sponsors conducting trials in multiple countries recruit too many patients from the country, said the study published in PLOS One journal. "The Indian drug regulator needs to be particularly alert to the planned, or actual, over-recruitment of participants from India," the researchers said in the study.
Researchers have found that 26 of 424 multinational clinical trials by foreign sponsors to evaluate candidate drugs against asthma, bacterial infections, cancer and other conditions had recruited or planned to recruit 60 per cent or more of the trial volunteers from India
Research finds over-recruitment of Indian participants in global clinical trials firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.
Buzzing breakthrough: genetic engineering gives mosquito control an upgrade thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
IBAB Bangalore is an autonomous institution that was founded in 2001. It was founded by the Karnataka governments Department of IT, BT, and S&T. At the graduate level, it provides M.Sc. and PG Diploma programmes. IBAB Bangalore also provides a Ph.D. programme in a variety of specialisations.